Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Epilepsy Clinical Trials
Epilepsy clinical trials are recruiting across 106 cities. Here are the cities with the most active studies:
Epilepsy Trial Phases
62 research organizations are sponsoring epilepsy trials.
About Epilepsy
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects about 50 million people worldwide. Treatment includes antiseizure medications, surgery, and neurostimulation devices.
Clinical trials are advancing new treatments for epilepsy. Currently, 100 studies are recruiting a combined 159,118 participants across the United States. Research is being conducted by 62 organizations including Epilepsy Foundation of America, University of New Mexico, Stanford University and 59 others.
2026 Epilepsy Research Landscape
As of July 2026, the epilepsy clinical trial landscape includes 100 actively recruiting studies across 106 cities in the United States. These studies are collectively seeking 159,118 participants, with an average enrollment target of 1,591 per study.
The research spans multiple phases of development: 46 studies are in NA, 16 studies are in PHASE3, 11 studies are in PHASE2, 4 studies are in PHASE1, 3 studies are in EARLY_PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some epilepsy treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 62 different organizations, including Epilepsy Foundation of America, University of New Mexico, Stanford University, Boston Children's Hospital, Harvard University Faculty of Medicine, and 57 others. The large number of sponsors reflects significant research interest and investment in epilepsy treatment advancement.
Geographically, epilepsy trials are most concentrated in Boston, Massachusetts (16 trials); Phoenix, Arizona (11 trials); Los Angeles, California (10 trials); Bethesda, Maryland (10 trials); Houston, Texas (9 trials) and 7 other cities.
Featured Epilepsy Studies
Highlighted recruiting studies for epilepsy, selected by enrollment size and research scope.
Epilepsy Learning Healthcare System (ELHS)
The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy. The ELHS is designed as a model of value-based chronic care for epilepsy as envisioned by the National Academies of Medicine Committee in their landmark reports "The Learning Health System" and "Epilepsy Across the Spectrum: Promoting Health and Understanding". Th...
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
This proposal outlines the steps required for the creation of a pilot database of EEG recordings and de-identified medical records from patients internally referred within the UNMH Comprehensive Epilepsy Center. The UNMH EEG Corpus would be the first database of its kind. Other public databases contain either patient EEG signals or medical records, but without both kinds of information, it is impo...
Pediatric Dose Optimization for Seizures in Emergency Medical Services
The Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study is designed to improve how paramedics treat seizures in children on ambulances. Seizures are one of the most common reasons why people call an ambulance for a child, and paramedics typically administer midazolam to stop the seizure. One-third of children with active seizures on ambulances arrive at emergenc...
Frequently Asked Questions About Epilepsy Clinical Trials
Are there epilepsy clinical trials near me?
Yes, there are 100 epilepsy clinical trials currently recruiting across 106+ cities in the United States, including Boston, Massachusetts; Phoenix, Arizona; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a epilepsy clinical trial?
To join a epilepsy clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are epilepsy clinical trials free?
Yes, participation in epilepsy clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of epilepsy treatments are being studied?
Current epilepsy clinical trials are testing a range of approaches across NA (46 studies), PHASE3 (16 studies), PHASE2 (11 studies), PHASE1 (4 studies), EARLY_PHASE1 (3 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 62 research organizations.
Is it safe to participate in epilepsy clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 19, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 19, 2026 · Data from ClinicalTrials.gov